首页 | 本学科首页   官方微博 | 高级检索  
检索        

老年2型糖尿病合并代谢综合征患者的治疗方式和控制达标状况调查
引用本文:孙敬芳,李春霖,田慧,宗文漪,邵迎红,闫双通,李剑.老年2型糖尿病合并代谢综合征患者的治疗方式和控制达标状况调查[J].解放军医学杂志,2007,32(10):1014-1016.
作者姓名:孙敬芳  李春霖  田慧  宗文漪  邵迎红  闫双通  李剑
作者单位:解放军总医院老年内分泌科,北京,100853
摘    要:目的 了解老年2型糖尿病(T2DM)合并代谢综合征(MS)患者的临床特点、用药情况及代谢异常组分的控制达标状况.方法 回顾性分析2001~2005年住院的老年T2DM患者共349例,其中合并MS者194例,观察194例患者的临床特点、用药情况以及各代谢异常组分控制达标水平.结果 老年T2DM合并MS者的比例为55.6%,体重指数(BMI)、餐后血糖、血压和甘油三酯(TG)均高于T2DM不合并MS组,HDL-C低于不合并MS组(P<0.05).老年T2DM合并MS的患者中,91.2%应用药物控制血糖,以双胍类、磺脲类、胰岛素为主,所占比例分别为59.3%、48.4%和36.1%;77.3%服用降压药物,以钙拮抗剂和血管紧张素转换酶抑制剂(ACEI)为主,分别为47.3%和46.2%;56.3%服用降脂药物,所占比例他汀类为34.8%,贝特类为71.4%.194例患者中,血糖各项均达标者占18.6%,血压整体达标者占40.9%,血脂四项全部达标者占29.3%.结论 老年T2DM合并MS的比例很高,虽然积极用药控制,但是各代谢异常组分的控制达标率并不理想.对于血糖而言,在联合口服药物治疗效果不佳时,应使用胰岛素治疗.

关 键 词:代谢综合征  糖尿病  2型  老年人  老年  型糖尿病  代谢综合征  患者  治疗方式  控制血糖  达标率  状况  调查  elderly  patients  metabolic  syndrome  combined  diabetes  mellitus  type  control  treatment  使用  效果不佳  药物治疗  血脂四项
修稿时间:2007-05-16

Investigation on the treatment and control of type 2 diabetes mellitus combined with metabolic syndrome in elderly patients
Sun Jingfang, Li Chunlin, Tian Hui,et al..Investigation on the treatment and control of type 2 diabetes mellitus combined with metabolic syndrome in elderly patients[J].Medical Journal of Chinese People's Liberation Army,2007,32(10):1014-1016.
Authors:Sun Jingfang  Li Chunlin  Tian Hui  
Institution:Department of Elderly Endocrinology, General Hospital of PLA, Beijing 100853, China
Abstract:objective To understand the clinical features of type 2 diabetes mellitus (T2DM) combined with metabolic syndrome (MS) in elderly patients, as well as the medicine used for treatment and the distribution of abnormal metabolic components. Methods Totally 349 T2DM patients admitted from 2001 to 2005 were retrospectively studied, among them 194 patients were combined with MS. The clinical data of those 194 patients were analyzed to evaluate their clinical feature, medicine used and the distribution of several abnormal metabolic components. of T2DM combined with MS. Results The proportion of MS in the elderly T2DM patients was 55.6%. Body mass index (BMI), postprandial blood glucose (PBG), blood pressure and triglyceride (TG) were higher than that in those patients of T2DM without MS, while the high density lipoprotein cholesterol (HDL-C) was lower (P<0.05). 91.2% diabetes patients was suffered from MS, for whom the medicine was used to control the blood glucose, including biguanides (59.3%), sulfonylureas (48.4%) and insulin (36.1%). Among the 194 patients, 150 (77.3%) with hypertension were to use medicine for controlling blood pressure, including calcium-antagon (47.3%) and angiotensin-converting enzyme inhibitor(ACEI, 46.2%). There were 56.3% of 194 patients who took medicine for controlling blood lipid, including statin and fenofibrate (34.8% and 71.4%, respectively). Among the 194 patients, 18.6%, 40.9% and 29.3% were up to the normal level on blood glucose, blood pressure and blood lipid, respectively. Conclusion The incidence of MS is higher in the elderly T2DM patients. It's hard to get an ideal result on controlling the abnormal metabolic components even though several drugs have been used. For the patients with high blood glucose, it's better to use insulin when the other medicine can not led to a satisfactory effect.
Keywords:metabolic syndrome  diabetes mellitus  type 2  aged
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号